Beacon Pointe Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Sell |
33,363
-4
| -0% | -$1.62K | 0.14% | 140 |
|
|
2025
Q1 | $16.6M | Buy |
33,367
+2,660
| +9% | +$1.32M | 0.19% | 118 |
|
|
2024
Q4 | $16M | Sell |
30,707
-4,597
| -13% | -$2.39M | 0.18% | 126 |
|
|
2024
Q3 | $21.8M | Sell |
35,304
-719
| -2% | -$445K | 0.25% | 92 |
|
|
2024
Q2 | $19.9M | Buy |
36,023
+461
| +1% | +$255K | 0.24% | 97 |
|
|
2024
Q1 | $20.7M | Sell |
35,562
-16,122
| -31% | -$9.37M | 0.23% | 103 |
|
|
2023
Q4 | $27.4M | Buy |
51,684
+2,944
| +6% | +$1.56M | 0.33% | 65 |
|
|
2023
Q3 | $24.7M | Buy |
48,740
+13,746
| +39% | +$6.96M | 0.31% | 78 |
|
|
2023
Q2 | $18.3M | Sell |
34,994
-3,332
| -9% | -$1.74M | 0.3% | 76 |
|
|
2023
Q1 | $22.1M | Buy |
38,326
+5,663
| +17% | +$3.26M | 0.38% | 64 |
|
|
2022
Q4 | $18M | Buy |
32,663
+904
| +3% | +$498K | 0.35% | 73 |
|
|
2022
Q3 | $16.1M | Sell |
31,759
-737
| -2% | -$375K | 0.36% | 71 |
|
|
2022
Q2 | $17.7M | Sell |
32,496
-10,778
| -25% | -$5.86M | 0.37% | 65 |
|
|
2022
Q1 | $25.6M | Buy |
43,274
+20,950
| +94% | +$12.4M | 0.35% | 65 |
|
|
2021
Q4 | $14.9M | Sell |
22,324
-8,908
| -29% | -$5.94M | 0.39% | 60 |
|
|
2021
Q3 | $17.8M | Buy |
31,232
+23,690
| +314% | +$13.5M | 0.44% | 54 |
|
|
2021
Q2 | $3.8M | Buy |
7,542
+3,857
| +105% | +$1.95M | 0.13% | 153 |
|
|
2021
Q1 | $1.68M | Sell |
3,685
-434
| -11% | -$198K | 0.1% | 155 |
|
|
2020
Q4 | $1.92M | Buy |
4,119
+592
| +17% | +$276K | 0.13% | 133 |
|
|
2020
Q3 | $1.56M | Buy |
3,527
+663
| +23% | +$293K | 0.15% | 126 |
|
|
2020
Q2 | $1.04M | Buy |
2,864
+680
| +31% | +$246K | 0.1% | 162 |
|
|
2020
Q1 | $621K | Buy |
+2,184
| New | +$621K | 0.1% | 154 |
|